The impact of stress-induced DNA breaks on chromatin structure, gene activity, and neuron function
应激诱导的 DNA 断裂对染色质结构、基因活性和神经元功能的影响
基本信息
- 批准号:10655982
- 负责人:
- 金额:$ 79.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-05 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgonistArchitectureAreaAtrophicAutomobile DrivingBehaviorBehavioralBehavioral SymptomsBrainBrain regionBrain-Derived Neurotrophic FactorBreedingCandidate Disease GeneChIP-seqChromatinChromatin Conformation Capture and SequencingChromatin LoopChromatin StructureChronicChronic stressClinical ResearchCognitionCognitiveCognitive deficitsComplexConfocal MicroscopyDLG4 geneDNADNA Double Strand BreakDiazepamERG geneEarly PromotersEnhancersEnzymesEpigenetic ProcessEtoposideExposure toFOSB geneFRAP1 geneGene ExpressionGenesGenetic TranscriptionGenome MappingsGenotypeHeterochromatinHippocampusHourInfusion proceduresKnowledgeLabelLengthMajor Depressive DisorderMapsMediatingMental disordersMolecularMusNPAS4 geneNeurobehavioral ManifestationsNeurobiologyNeuronsPathway interactionsPatternPoisonPost-Traumatic Stress DisordersPrefrontal CortexProsencephalonProteinsRecurrenceReportingRodentRoleSiteSortingStressStressful EventStructureSynapsesSynaptic plasticitySynaptosomesTestingTopoisomeraseWorkcandidate identificationchromatin remodelingchromosome conformation capturecohortdensityexperienceexperimental studygenome-widegenomic locusgephyrininhibitorinsightlateral ventriclenervous system disordernovelnovel therapeutic interventionosmotic minipumppreclinical studypromoterreceptortranscriptome sequencing
项目摘要
PROJECT SUMMARY:
Chronic stress causes molecular adaptations and structural remodeling of neurons within corticolimbic
brain areas, including the prefrontal cortex (PFC) and hippocampus (HPC). This is important because the PFC
and HPC are integrated in brain circuits that regulate complex behaviors and cognition. Preclinical and clinical
studies indicate that synapse loss and reduced connectivity in the PFC and HPC contribute to behavioral and
cognitive symptoms in several psychiatric disorders, such as post-traumatic stress disorder (PTSD) and major
depressive disorder (MDD). While previous reports have identified candidate genes and pathways, the molecular
mechanisms that cause lasting stress-induced changes in gene activity patterns and structural remodeling in
neurons remain unknown. In preliminary studies, exposing mice to chronic unpredictable stress (CUS) triggered
the formation of DNA double strand breaks (DSBs) within stress-activated neurons in the PFC. Administration of
the GABAA receptor agonist, diazepam, diminished both the number of stress-activated neurons and the levels
of DSBs, suggesting that stress-induced DSBs are generated by activity-dependent mechanisms. Accumulating
evidence indicates that neuronal activity induces the topoisomerase, topoisomerase II (Top2B) to generate
DSBs and promote the transcription of an important subset of genes that mediate experience-driven synaptic
changes, including early response genes (ERGs), such as Fos, Npas4, Egr1, and Arc. These results suggest
that experience-dependent DSB formation could regulate stress-induced gene activity patterns and subsequent
remodeling of neurons. Yet the sites of stress-induced DSBs in PFC and HPC neurons have not been mapped
and how DSBs affect stress-related gene activity patterns has not been explored.
Interestingly, preliminary studies revealed that recurrent and ectopic induction of Top2B-mediated DSBs
in cultured neurons is sufficient to recapitulate chronic stress-induced gene expression profiles for various
neuronal activity-responsive genes, including ERGs and Bdnf. Preliminary chromosome conformation capture
(3C)-based experiments (3C and 4C-seq) further suggest that DSBs regulate gene activity patterns by altering
chromatin topology. These observations have led to the hypothesis that recurrent DSB formation during chronic
stress alters chromatin architecture at associated genes, which in turn, stabilizes stress-related gene activity
patterns that trigger neuronal remodeling and synapse loss in the PFC and HPC. To test this hypothesis, the
proposed studies will map genome-wide sites of CUS-induced DSBs and utilize conditional deletion of Top2b to
define how DSBs affect stress-dependent changes in transcription and neuronal structure and function in PFC
and HPC projection neurons. Additionally, 3C-based methods (HiChIP) will be employed to assess how DSBs
affect stress-dependent changes to chromatin architecture. Together, these efforts will provide novel insights
into the mechanisms driving stress-induced neuronal adaptations, and may uncover new therapeutic strategies
for psychiatric disorders, such as PTSD and MDD.
项目总结:
慢性应激引起皮质边缘神经元的分子适应和结构重塑
大脑区域,包括前额叶皮质(PFC)和海马体(HPC)。这一点很重要,因为PFC
和HPC整合在大脑回路中,调节复杂的行为和认知。临床前和临床
研究表明,PFC和HPC的突触丢失和连接性降低有助于行为和
几种精神障碍的认知症状,如创伤后应激障碍(PTSD)和
抑郁障碍(MDD)。虽然以前的报告已经确定了候选基因和途径,但分子
导致持续应激诱导的基因活性模式改变和结构重塑的机制
神经元仍然是未知的。在初步研究中,将小鼠暴露在慢性不可预测的应激(CUS)中会引发
前额叶核内应激激活神经元DNA双链断裂的形成。管理
GABAA受体激动剂地西潘减少了应激激活神经元的数量和水平
这表明应激诱导的双链断裂是由活性依赖机制产生的。积累
有证据表明,神经元活动诱导拓扑异构酶(Top2B)产生
DSB并促进介导体验驱动突触的重要基因子集的转录
变化,包括早期反应基因(ERGs),如Fos、Npas4、Egr1和Arc。这些结果表明
依赖经验的DSB的形成可以调节压力诱导的基因活动模式和随后的
神经元的重塑。然而,应激诱导的PFC和HPC神经元中DSB的位置还没有被定位
DSB如何影响与压力相关的基因活动模式还没有被探索过。
有趣的是,初步研究表明,Top2B介导的DSB的反复和异位诱导
足以概括慢性应激诱导的各种基因表达谱
神经元活性反应基因,包括ERGs和BDNF。初步捕获染色体构象
基于(3C)的实验(3C和4C-SEQ)进一步表明,DSB通过改变基因活性模式来调节基因活动模式
染色质拓扑。这些观察结果导致了一种假设,即慢性阻塞性肺疾病期间复发的DSB的形成
压力改变相关基因的染色质结构,进而稳定压力相关基因的活性。
触发PFC和HPC神经元重塑和突触丢失的模式。为了检验这一假设,
拟议的研究将绘制CUS诱导的DSB的全基因组位置图,并利用Top2b的条件删除来
明确DSB如何影响PFC中应激依赖的转录和神经元结构和功能的变化
和HPC投射神经元。此外,还将采用基于3C的方法(HiChIP)来评估DSB
影响染色质结构的应激依赖变化。总而言之,这些努力将提供新的见解
研究应激诱导神经元适应的机制,并可能发现新的治疗策略
用于精神障碍,如创伤后应激障碍和MDD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ram Madabhushi其他文献
Ram Madabhushi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ram Madabhushi', 18)}}的其他基金
Mechanisms regulating the formation and repair of neuronal activity-induced DNA breaks and their effects on learning behavior
神经元活动诱导的 DNA 断裂形成和修复的调节机制及其对学习行为的影响
- 批准号:
10376801 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
Mechanisms regulating the formation and repair of neuronal activity-induced DNA breaks and their effects on learning behavior
神经元活动诱导的 DNA 断裂形成和修复的调节机制及其对学习行为的影响
- 批准号:
10596091 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




